Susquehanna Fundamental Investments, LLC Mannkind Corp Call Options Transaction History
Susquehanna Fundamental Investments, LLC
- $6.94 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MNKD
# of Institutions
272Shares Held
170MCall Options Held
1.37MPut Options Held
652K-
Black Rock Inc. New York, NY22.6MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$85.9 Million0.0% of portfolio
-
State Street Corp Boston, MA9.47MShares$47 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$43.4 Million0.71% of portfolio
-
Nitorum Capital, L.P. New York, NY8.75MShares$43.4 Million8.23% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.28B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...